Advanced search
Publication Cover
Acta Oncologica Volume 51, 2012 - Issue 1
Journal homepage
1,057
Views
12
CrossRef citations to date
0
Altmetric
Research Article

First-line treatment of patients with disseminated poorly differentiated neuroendocrine carcinomas with carboplatin, etoposide, and vincristine: A single institution experience

Ingrid Holst OlsenDepartment of Oncology 5073, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark;Department of Surgery C 2122, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark;Department of Clinical Physiology, Nuclear Medicine & PET 4011, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark;Cluster for Molecular Imaging, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark;European NET Centre of Excellence, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark
,
Seppo W. LangerDepartment of Oncology 5073, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark;European NET Centre of Excellence, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, DenmarkCorrespondence[email protected]
,
Ida JepsenEuropean NET Centre of Excellence, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark
,
Maria AssensEuropean NET Centre of Excellence, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark
,
Birgitte FederspielDepartment of Pathology 5442, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark;European NET Centre of Excellence, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark
,
Jane Preuss HasselbyDepartment of Pathology 5442, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark;European NET Centre of Excellence, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark
,
Carsten Palnæs HansenDepartment of Surgery C 2122, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark;European NET Centre of Excellence, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark
,
Andreas KjærDepartment of Clinical Physiology, Nuclear Medicine & PET 4011, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark;Cluster for Molecular Imaging, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark;European NET Centre of Excellence, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark
&
Ulrich KniggeDepartment of Surgery C 2122, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark;Cluster for Molecular Imaging, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark;European NET Centre of Excellence, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark
 show all
Pages 97-100 | Received 13 Jan 2011, Accepted 16 Apr 2011, Published online: 26 May 2011

References

  • Moertel CG, Kvols LK, O’Connell MJ, Rubin J. Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms. Cancer 1991;68:227–32.
  • Mitry E, Baudin E, Ducreux M, Sabourin JC, Rufie P, Aparicio T, . Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer 1999;81:1351–5.
  • Oberg K, Astrup L, Eriksson B, Falkmer SE, Falkmer UG, Gustafsen J, . Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms). Part I – general overview. Acta Oncol 2004;43:617–25.
  • Janson ET, Sorbye H, Welin S, Federspiel B, Gronbaek H, Hellman P, . Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours. Acta Oncol 2010;49:740–56.
  • Johnson LA, Lavin P, Moertel CG, Weiland L, Dayal Y, Doos WG, . Carcinoids: The association of histologic growth pattern and survival. Cancer 1983;51:882–9.
  • Rindi G, Bordi C, Rappel S, La RS, Stolte M, Solcia E. Gastric carcinoids and neuroendocrine carcinomas: Pathogenesis, pathology, and behavior. World J Surg 1996;20:168–72.
  • Hainsworth JD, Johnson DH, Greco FA. Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity. Ann Intern Med 1988;109:364–71.
  • Pelley RJ, Bukowski RM. Recent advances in diagnosis and therapy of neuroendocrine tumors of the gastrointestinal tract. Curr Opin Oncol 1997;9:68–74.
  • Moertel CG, Johnson CM, McKusick MA, Martin JK, Jr., Nagorney DM, Kvols LK, . The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 1994;120:302–9.
  • Nilsson O, Van CE, Delle FG, Yao JC, Pavel ME, McNicol AM, . Poorly differentiated carcinomas of the foregut (gastric, duodenal and pancreatic). Neuroendocrinology 2006;84:212–5.
  • Ahlman H, Nilsson O, McNicol AM, Ruszniewski P, Niederle B, Ricke J, . Poorly-differentiated endocrine carcinomas of midgut and hindgut origin. Neuroendocrinology 2008;87:40–6.
  • Oberg K. Chemotherapy and biotherapy in the treatment of neuroendocrine tumours. Ann Oncol 2001;12(Suppl 2):S111–4.
  • Yao JC, Hassan M, Phan A, Dagohoy C, Leary C, Mares JE, . One hundred years after “carcinoid”: Epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol 2008;26:3063–72.
  • National Comprehensive Cancer Network [Internet]. Fort Washington: NCCN; 2009. Clinical practice guidelines in oncology: Neuroendocrine tumors v.2.2009. Available from: http://www.nccn.org/professionals/physician_gls/PDF/neuroendocrine.pdf.
  • Binderup T, Knigge U, Loft A, Federspiel B, Kjaer A. 18F-fluorodeoxyglucose positron emission tomography predicts survival of patients with neuroendocrine tumors. Clin Cancer Res 2010;16:978–85.
  • Langer SW, Sorensen M. Treatment of small cell lung cancer. Hansen HH. London: Informa; 2009.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.